ACS - risk stratification: Difference between revisions
Neil.m.young (talk | contribs) (Reverted edits by Neil.m.young (talk) to last revision by Rossdonaldson1) |
Ostermayer (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
==HEART Score== | ==HEART Score== | ||
{{HEART Score}} | |||
==New Vancouver Chest Pain Rule== | ==New Vancouver Chest Pain Rule== | ||
Revision as of 03:29, 26 April 2017
HEART Score
- The score has been derived and validated in an ED population and predicts 6 week adverse cardiac events[1][2]
HEART Score
| Criteria | Select One | ||
|---|---|---|---|
| History | Slightly suspicious (0) | Moderately suspicious (+1) | Highly suspicious (+2) |
| EKG | Normal (0) | Non-specific repolarization disturbance (+1) | Significant ST deviation (+2) |
| Age | <45 (0) | 45–64 (+1) | ≥65 (+2) |
| Risk Factors
HTN, hypercholesterolemia, DM, obesity (BMI >30), smoking, family hx CVD, or hx atherosclerotic disease |
No known risk factors (0) | 1–2 risk factors (+1) | ≥3 risk factors or hx atherosclerotic disease (+2) |
| Initial Troponin | ≤normal limit (0) | 1–3× normal limit (+1) | >3× normal limit (+2) |
| HEART Score | / 10 | ||
| 0–3 | Low Risk — 0.9–1.7% risk of MACE. Consider discharge with outpatient follow-up. |
|---|---|
| 4–6 | Moderate Risk — 12–16.6% risk of MACE. Consider admission for observation and further workup. |
| 7–10 | High Risk — 50–65% risk of MACE. Consider early invasive measures (cardiology consult, catheterization). |
| References |
|---|
|
New Vancouver Chest Pain Rule
- Useful for screening patient with low risk for ACS
- The old Vancouver chest pain rule was not properly validated[3][4] [4]
- The new rule was validated in 2014 on 1635 patients and published in 2014[5]
- With high sensitivity troponins the sensitivity is 99.1% (95% CI 97.4-99.7), & specificity is 16.1 (95% CI 14.2-18.2)
- With sensitive troponin-I the sensitivity was 98.8% (97.0-99.5), & specificity of 15.8 (13.9-17.9)
Algorithm
- Is the same for c-TnI assay and hs-TnI assay but sensitivity differences by a percentage point
- Is there an abnormal ECG, positive troponin at 2 hrs or prior ACS nitrate use?
- If Yes to any then no early discharge
- Does palpation reproduce the pain?
- If Yes then early discharge
- Age ≥50, or does pain radiate to neck, jaw, or left arm?
- If Yes then no early discharge
- If answer is No to all of the above stepwise questions then the patient can have early discharge with close follow-up for further provocative testing
Likelihood That Signs/Symptoms Represent ACS due to CAD
| Feature | High Likelihood (any of the following) | Intermediate Likelihood (absence of high-likelihood features and presence of any of the following) | Low Likelihood (absence of high- or intermediate-likelihood features but may have) |
|---|---|---|---|
| History | Chest or left arm pain or discomfort as chief symptom reproducing prior documented angina | Chest or left arm pain or discomfort as chief symptom | Probable ischemic symptoms in absence of any of the intermediate-likelihood characteristics |
| Known history of coronary artery disease, including myocardial infarction | Age >70 y old | Recent cocaine use | |
| Male sex | |||
| Diabetes mellitus | |||
| Examination | Transient mitral regurgitation murmur, hypotension, diaphoresis, pulmonary edema, or rales | Extracardiac vascular disease | Chest discomfort reproduced by palpation |
| ECG | New, or presumably new, transient ST-segment deviation (1 mm or greater) or T-wave inversion in multiple precordial leads | Fixed Q waves | T-wave flattening or inversion <1 mm in leads with dominant R waves |
| ST depression 0.5–1.0 mm or T-wave inversion >1 mm | |||
| Normal ECG | |||
| Cardiac markers | Elevated cardiac troponin I, troponin T, or MB fraction of creatine kinase | Normal | Normal |
Short-Term Risk of Composite Outcome
Composite Outcome: Death or Nonfatal Myocardial Infarction by Risk Stratification in Patients with Unstable Angina
| Feature | High Likelihood (at least one of the following features must be present) | Intermediate Likelihood (no high-risk feature, but must have one of the following) | Low Likelihood (no high- or intermediate-risk feature, but may have any of the following) |
|---|---|---|---|
| History | Accelerating tempo of ischemic symptoms in preceding 48 h | Prior myocardial infarction, peripheral or cerebrovascular disease, or coronary artery bypass grafting; prior aspirin use | — |
| Character of the pain | Prolonged ongoing (>20 min) rest pain | Prolonged (>20 min) rest angina, now resolved, with moderate or high likelihood of CAD | Increased angina frequency, severity, or duration |
| Rest angina (>20 min) or relieved with rest or sublingual nitroglycerin | Angina provoked at a lower threshold | ||
| New-onset angina with onset 2 wk to 2 mo before presentation | |||
| Nocturnal angina | |||
| New-onset or progressive Canadian Cardiology Society Class III or IV angina in the past 2 wk without prolonged (>20 min) rest pain but with intermediate or high likelihood of CAD; | |||
| Clinical findings | Pulmonary edema, most likely due to ischemia | Age >70 y old | Chest discomfort reproduced by palpation |
| New or worsening mitral regurgitation murmur | |||
| S3 or new/worsening rales | |||
| Hypotension, bradycardia, tachycardia | |||
| Age >75 y old | |||
| ECG | Angina at rest with transient ST-segment changes >0.5 mm | T-wave changes, pathologic Q waves, or resting ST depression <1 mm in multiple lead groups (anterior, inferior, lateral) | Normal or unchanged ECG |
| Bundle-branch block, new or presumed new | |||
| Sustained ventricular tachycardia | |||
| Cardiac markers | Elevated cardiac TnT, TnI, or CK-MB (e.g., TnT or TnI >0.1 nanogram/mL) | Slightly elevated cardiac TnT, TnI, or CK-MB (e.g., TnT >0.01 but <0.1 nanogram/mL) | Normal |
TIMI Risk Stratification Score
NSTEMI TIMI Score[6]
- Used to estimate percent risk of all-cause mortality, new/recurrent MI, or need for revascularization at 14 days
- Age >65 yrs (1 point)
- Three or more risk factors for coronary artery disease: (1 point)
- family history of coronary artery disease
- hypertension
- hypercholesterolaemia
- diabetes
- current smoker
- Use of aspirin in the past 7 days (1 point)
- Significant coronary stenosis (stenosis >50%) (1 point)
- Severe angina (e.g., >2 angina events in past 24 h or persisting discomfort) (1 point)
- ST-segment deviation of ≥0.05 mV on first ECG (1 point)
- Increased troponin and/or creatine kinase-MB blood tests (1 point)
| points | % risk of mortality, MI, or need for revascularization |
|---|---|
| 0 | 5% |
| 1 | 5% |
| 2 | 8% |
| 3 | 13% |
| 4 | 20% |
| 5 | 26% |
| 6 | 41% |
See Also
References
- ↑ Six AJ, Backus BE, Kelder JC. Chest pain in the emergency room: value of the HEART score. Neth Heart J. 2008 Jun;16(6):191-6.PMID 18665203
- ↑ Backus BE, Six AJ, Kelder JC, Bosschaert MA. et al. A prospective validation of the HEART score for chest pain patients at the emergency department. Int J Cardiol. 2013 Oct 3;168(3):2153-8 PMID 2346525
- ↑ Jalili M. Validation of the Vancouver Chest Pain Rule: a prospective cohort study. Acad Emerg Med. 2012 Jul;19(7):837-42.
- ↑ 4.0 4.1 Christenson J. A clinical prediction rule for early discharge of patients with chest pain. Ann Emerg Med. 2006 Jan;47(1):1-10.
- ↑ Cullen L et al. The new Vancouver Chest Pain Rule using troponin as the only biomarker: an external validation study. Am J Emerg Med. 2014 Feb;32(2):129-34
- ↑ Antman, Elliot et al. The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI A Method for Prognostication and Therapeutic Decision Making. JAMA. 2000;284(7):835-842. doi:10.1001/jama.284.7.835. PDF
